Frontlight ResearchEarly access
Trial site
Johns Hopkins Asthma and Allergy Center
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- United Therapeutics2 trials
- argenx1 trial
- Avalyn Pharma Inc.1 trial
- Celldex Therapeutics1 trial
Running trials
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Active, not recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Recruiting
Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Idiopathic pulmonary fibrosis3 recruiting
Site data: ClinicalTrials.govUpdated 15 Nov 2026